Sun Pharma is one of India’s leading pharmaceutical companies, known for its strong presence in the global market. Investors closely follow its share price, as it is influenced by various factors like company growth, industry trends, and regulatory developments. Understanding these factors can help investors make informed decisions. Sun Pharma Share Price on 15 February 2025 is 1,702.00 INR. This article will provide more details on Sun Pharma Share Price Target 2025, 2026 to 2030.
Sun Pharma Share Price Chart
Sun Pharma Share Details
- Open: 1,747.35
- High: 1,748.95
- Low: 1,685.00
- Previous Close: 1,746.35
- Volume: 2,123,774
- Value (Lacs): 36,114.78
- VWAP: 1,703.76
- UC Limit: 1,920.95
- LC Limit: 1,571.75
- 52 Week High: 1,960.35
- 52 Week Low: 1,377.20
- Mkt Cap (Rs. Cr.): 408,006
- Face Value: 1
Sun Pharma Share Price Target 2025 To 2030
- 2025 – ₹1965
- 2026 – ₹2180
- 2027 – ₹2300
- 2028 – ₹2500
- 2029 – ₹2700
- 2030 – ₹2900
Sun Pharma Shareholding Pattern
- Promoters: 54.48%
- Mutual Funds: 12.24%
- Foreign Institutions: 18.05%
- Domestic Institutions: 6.31%
- Retail and Other: 8.92%
Major Factors Affecting Sun Pharma Share Price
-
Company Performance and Financial Results
Sun Pharma’s quarterly and annual financial reports significantly impact its share price. Higher revenue, profit growth, and strong operating margins boost investor confidence, leading to a rise in stock value. On the other hand, declining earnings or unexpected losses can negatively affect the share price. -
Regulatory Approvals and Compliance
Being a pharmaceutical company, Sun Pharma is highly dependent on regulatory approvals from authorities like the US FDA, DCGI, and other global agencies. A positive approval for new drugs or manufacturing facilities can increase investor trust, while warnings or bans can lead to a stock decline. -
Research and Development (R&D) Investments
Innovation and new drug development play a crucial role in Sun Pharma’s future growth. High R&D investments leading to successful drug launches improve its market position and push the share price higher. However, if R&D spending does not yield expected results, it may raise concerns among investors. -
Global and Domestic Market Demand
Sun Pharma operates in various international markets, making its stock price sensitive to demand changes worldwide. Increased demand for medicines, especially in emerging markets, strengthens the company’s revenue and stock value, while economic slowdowns or reduced healthcare spending can have a negative impact. -
Foreign Exchange Fluctuations and Global Trade Policies
Since Sun Pharma exports a significant portion of its products, currency exchange rates can affect its earnings. A stronger rupee can reduce export earnings, negatively impacting the stock price, while a weaker rupee benefits the company. Additionally, trade restrictions or import/export policies in key markets can influence Sun Pharma’s growth and stock performance.
Risks and Challenges for Sun Pharma Share Price
-
Regulatory Hurdles and Compliance Issues
Sun Pharma operates in multiple countries, making it subject to various regulatory approvals and inspections. Any warning letters, bans, or non-compliance issues from authorities like the US FDA or India’s DCGI can negatively impact its reputation and share price. Stricter regulations can also delay new product launches, affecting growth. -
Patent Expiry and Generic Competition
The pharmaceutical industry faces intense competition from generic drug manufacturers. If Sun Pharma’s patents on key drugs expire, competitors can produce cheaper alternatives, reducing the company’s revenue and profitability. This increased competition can put downward pressure on the stock price. -
Global Economic and Currency Fluctuations
Since Sun Pharma earns a significant portion of its revenue from exports, it is affected by currency exchange rates. A stronger Indian rupee against the US dollar can lower export earnings, negatively impacting financial performance. Additionally, economic slowdowns in major markets can reduce demand for medicines, affecting overall growth. -
Legal and Litigation Risks
The pharmaceutical industry is prone to lawsuits related to drug safety, intellectual property, and compliance. Sun Pharma has faced legal battles in the past, and any future lawsuits or settlements can lead to financial losses, reputational damage, and a decline in investor confidence, impacting share prices. -
Dependence on Key Markets and Supply Chain Disruptions
Sun Pharma relies heavily on markets like the US, Europe, and India for a major part of its revenue. Any unfavorable policies, pricing pressures, or trade restrictions in these regions can hurt the company’s business. Additionally, disruptions in raw material supply, manufacturing delays, or global crises (like pandemics) can impact production and sales, affecting stock performance.
Read Also:- Rattanindia Power Share Price Target 2025 To 2030- Chart, Market Overview, More Details